Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation

Absztrakt
Leírás
Kulcsszavak
Forrás
The Journal of Pathology: Clinical Research. -10 : 1 (2024), p. 1-12. -The Journal of Pathology CR. - 2056-4538. - 2056-4538